false
OasisLMS
Catalog
Multiprofessional Critical Care Review: Adult 2024 ...
4: Bleeding and Coagulation Disorders: What Am I t ...
4: Bleeding and Coagulation Disorders: What Am I to Do with Those New Agents? (Janice Zimmerman, MD, MCCM, MACP)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video presentation discusses bleeding and coagulation disorders. The speaker emphasizes the importance of identifying the underlying defect before reaching for lab results. They suggest considering the patient's history, clinical signs, and other medical conditions to guide diagnosis. Various lab tests such as platelet count, prothrombin time, partial thromboplastin time, and D-dimer are discussed as ways to assess platelet function and coagulation cascade. The speaker also touches on viscoelastic assays like thromboelastography, which provide a global picture of coagulation and can guide transfusion decisions. Specific disorders such as thrombotic thrombocytopenic purpura, immune thrombocytopenia, disseminated intravascular coagulation, heparin-induced thrombocytopenia, and von Willebrand disease are discussed. The speaker also provides information on managing bleeding in patients taking antiplatelet agents, warfarin, and direct oral anticoagulants. They discuss treatment options such as platelet transfusion, fresh frozen plasma, prothrombin complex concentrate, and specific reversal agents for certain anticoagulants. The speaker concludes by highlighting the need to tailor treatment to each patient's specific circumstances and needs.
Keywords
bleeding disorders
coagulation disorders
underlying defect
platelet count
prothrombin time
D-dimer
thromboelastography
specific disorders
×
Please select your language
1
English